XLONELM
Market cap1.03bUSD
Dec 24, Last price
139.60GBP
1D
1.60%
1Q
-10.05%
Jan 2017
-45.01%
Name
Elementis PLC
Chart & Performance
Profile
Elementis plc operates as a specialty chemical company in the United Kingdom, North America, rest of Europe, and internationally. It operates through four segments: Personal Care, Coatings, Talc, and Chromium. The Personal Care segment produces and sells rheological modifiers and compounded products for antiperspirants/deodorants, bath and soap, color cosmetics, and hair and skin care products. The Coatings segment produces and sells rheological modifiers and additives for industrial finishes, architectural coatings, construction, adhesives and sealants, inks, colorant dispersions, and specialty applications; and bentonite and hectorite clays, as well as polymer-based additives used in drilling, simulation, and cementing applications. The Talc segment produces and supplies talc for use in plastics, paints and coatings, food and pharmaceuticals, ceramics, polyester putties, paper, and pulp sectors. The Chromium segment produces chromium chemicals, such as chromic oxide, chromic acid, chrome sulfate, sodium dichromate, and sodium sulfate for use in pigments, cosmetics, refractories, chrome metal production, metal and plastic finishing, wood treatment, leather tanning, trivalent metal finishing, coatings, and metal passivation, as well as for making detergents, glasses, papers, and starches. It also offers personal care products, waxes, additives and resins, organoclays, colourants, and other specialty additives. Elementis plc was founded in 1844 and is headquartered in London, the United Kingdom.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 713,400 -3.12% | 736,400 -16.33% | 880,100 17.14% | |||||||
Cost of revenue | 662,300 | 786,300 | 861,200 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 51,100 | (49,900) | 18,900 | |||||||
NOPBT Margin | 7.16% | 2.15% | ||||||||
Operating Taxes | 11,500 | 7,800 | 3,300 | |||||||
Tax Rate | 22.50% | 17.46% | ||||||||
NOPAT | 39,600 | (57,700) | 15,600 | |||||||
Net income | 26,500 -142.33% | (62,600) -2,604.00% | 2,500 -103.73% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (1,000) | 900 | 100 | |||||||
BB yield | 0.13% | -0.13% | -0.01% | |||||||
Debt | ||||||||||
Debt current | 5,900 | 8,800 | 6,400 | |||||||
Long-term debt | 331,200 | 481,200 | 556,500 | |||||||
Deferred revenue | (1,796,800) | |||||||||
Other long-term liabilities | 210,200 | 35,600 | 1,871,200 | |||||||
Net debt | 271,300 | 433,800 | 478,300 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 76,800 | 77,000 | 66,700 | |||||||
CAPEX | (38,100) | (47,100) | (53,100) | |||||||
Cash from investing activities | 101,100 | (46,900) | (65,000) | |||||||
Cash from financing activities | (168,000) | (57,800) | (25,300) | |||||||
FCF | 157,900 | (100,400) | (13,400) | |||||||
Balance | ||||||||||
Cash | 65,800 | 65,600 | 84,600 | |||||||
Long term investments | (9,400) | |||||||||
Excess cash | 30,130 | 19,380 | 40,595 | |||||||
Stockholders' equity | 608,100 | 545,200 | 660,200 | |||||||
Invested Capital | 1,328,270 | 1,233,620 | 1,440,105 | |||||||
ROIC | 3.09% | 1.10% | ||||||||
ROCE | 3.76% | 1.16% | ||||||||
EV | ||||||||||
Common stock shares outstanding | 596,900 | 592,300 | 588,800 | |||||||
Price | 1.28 5.98% | 1.20 -8.51% | 1.32 14.43% | |||||||
Market cap | 761,644 6.80% | 713,129 -7.97% | 774,861 13.49% | |||||||
EV | 1,032,944 | 1,146,929 | 1,253,161 | |||||||
EBITDA | 106,800 | 15,100 | 87,200 | |||||||
EV/EBITDA | 9.67 | 75.96 | 14.37 | |||||||
Interest | 20,200 | 21,600 | 27,500 | |||||||
Interest/NOPBT | 39.53% | 145.50% |